From: In vivo measurement of stent length by using intravascular ultrasound
Lesions (n = 95) | ||
---|---|---|
Lesion site (%) | LAD | 55 (57.9) |
LCX | 18 (18.9) | |
RCA | 22 (23.2) | |
Lesion typea (%) | Low risk | 41 (43.2) |
Moderate risk | 46 (48.4) | |
High risk | 8 (8.4) | |
Lesion length, mm | 9.09 (7.0–13.25) | |
Reference diameter, mm | 3.13 ± 0.64 | |
Prestent MLD, mm | 0.82 ± 0.32 | |
Prestent diameter stenosis (%) | 63.06 ± 14.87 | |
Poststent MLD, mm | 2.56 ± 0.44† | |
Poststent diameter stenosis (%) | 10.49 ± 5.50† | |
Drug-eluting stent (%) | 38 (40) | |
Bare metal stent (%) | 57 (60) | |
Stent diameter, mm (%) | 2.5 mm | 14 (14.74) |
3.0 mm | 54 (56.84) | |
3.5 mm | 23 (24.21) | |
4.0 mm | 4 (4.21) | |
Stent length, mm (%) | 8.0 mm | 2 (2.1) |
9.0 mm | 2 (2.1) | |
12.0 mm | 5 (5.3) | |
13.0 mm | 4 (4.2) | |
15.0 mm | 18 (18.9) | |
18.0 mm | 32 (33.7) | |
20.0 mm | 3 (3.2) | |
23.0 mm | 18 (18.9) | |
24.0 mm | 3 (3.2) | |
25.0 mm | 1 (1.1) | |
28.0 mm | 6 (6.3) | |
30.0 mm | 1 (1.1) | |
Stent strut (wire) thickness, mm | 0.14 (13.0–16.0) | |
Stent deployment pressure, atm | 16.0 (14.0–18.0) | |
Poststent balloon dilatation (%) | 19 (20%) |